MiMedx Group Inc
NASDAQ:MDXG
MiMedx Group Inc
Revenue
MiMedx Group Inc
Revenue Peer Comparison
Competitive Revenue Analysis
Latest Figures & CAGR of Competitors
Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
MiMedx Group Inc
NASDAQ:MDXG
|
Revenue
$321.5m
|
CAGR 3-Years
9%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
18%
|
|
Abbvie Inc
NYSE:ABBV
|
Revenue
$54.3B
|
CAGR 3-Years
6%
|
CAGR 5-Years
11%
|
CAGR 10-Years
11%
|
|
Gilead Sciences Inc
NASDAQ:GILD
|
Revenue
$27.5B
|
CAGR 3-Years
2%
|
CAGR 5-Years
4%
|
CAGR 10-Years
7%
|
|
Amgen Inc
NASDAQ:AMGN
|
Revenue
$28.2B
|
CAGR 3-Years
4%
|
CAGR 5-Years
3%
|
CAGR 10-Years
4%
|
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
Revenue
$9.9B
|
CAGR 3-Years
17%
|
CAGR 5-Years
26%
|
CAGR 10-Years
23%
|
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
Revenue
$13.1B
|
CAGR 3-Years
16%
|
CAGR 5-Years
14%
|
CAGR 10-Years
20%
|
MiMedx Group Inc
Revenue Breakdown
Breakdown by Geography
MiMedx Group Inc
Breakdown by Segments
MiMedx Group Inc
Total Revenue:
321.5m
USD
|
Hospital:
187m
USD
|
Private Office:
95.8m
USD
|
Other:
38.7m
USD
|
See Also
What is MiMedx Group Inc's Revenue?
Revenue
321.5m
USD
Based on the financial report for Dec 31, 2023, MiMedx Group Inc's Revenue amounts to 321.5m USD.
What is MiMedx Group Inc's Revenue growth rate?
Revenue CAGR 10Y
18%
Over the last year, the Revenue growth was 20%. The average annual Revenue growth rates for MiMedx Group Inc have been 9% over the past three years , -2% over the past five years , and 18% over the past ten years .